Synergistic actions of antibacterial neutrophil defensins and cathelicidins

Inflammation Research

Volumn 49, Issue 2, 2000, Pages 73-79

  Nagaoka, I ^a   Hirota, S ^a   Yomogida, S ^a   Ohwada, A ^a   Hirata, M ^b  

^a JUNTENDO UNIVERSITY   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Antibacterial peptide; Cathelicidin; Defensin; Membrane permeabilization; Neutrophil

Indexed keywords

ANTIINFECTIVE AGENT; CATHELICIDIN; DEFENSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG POTENTIATION; EXTRACELLULAR MATRIX; GUINEA PIG; MEMBRANE PERMEABILITY; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; TARGET CELL;

ALPHA-DEFENSINS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; CELL MEMBRANE PERMEABILITY; DEFENSINS; DRUG SYNERGISM; ESCHERICHIA COLI; GUINEA PIGS; HUMANS; MALE; NEUTROPHILS; PROTEINS; SODIUM CHLORIDE; STAPHYLOCOCCUS AUREUS;

EID: 0033995146     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050561     Document Type: Article

References (32)

1. [1] Elsbach P, Weiss J. Oxygen-independent antimicrobial systems of phagocytes. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: Basic Principles and Clinical Correlates. 2nd ed. New York: Raven Press, 1992: 603-36.
2. [2] Lehrer R, Ganz T, Selsted ME, Babior BM, Curnutte JT. Neutrophils and host defense. Ann Intern Med 1988; 109: 127-42.
3. [3] Spitznagel JK. Antibiotic proteins of human neutrophils. J Clin Invest 1990; 86: 1381-6.
4. [4] Boman H. Peptide antibiotics and their role on innate immunity. Annu Rev Immunol 1995; 13: 61-92.
5. [5] Ganz T, Selsted ME, Lehrer RI. Defensins. Eur J Haematol 1990; 44: 1-8.
6. [6] Lehrer RI. Defensins: antibacterial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 1993; 11: 105-28.
7. [7] Ganz T, Lehrer RI. Defensins. Curr Opin Immunol 1994; 6: 584-9.
8. [8] Martin E, Ganz T, Lehrer RI. Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol 1995; 58: 128-36.
9. [9] Levy O. Antibiotic proteins of polymorphonuclear leukocytes. Eur J Haematol 1996; 56: 263-77.
10. [10] Zanetti M, Gennaro R, Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 1995; 374: 1-5.
11. [11] Hirata M, Shimomura Y, Yoshida M, Morgan JG, Palings I, Wilson D, et al. Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Infect Immun 1994; 62: 1421-6.
12. [12] Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 1995; 63: 1291-7.
13. [13] Yomogida S, Nagaoka I, Yamashita T. Purification of the 11-and 5-kDa antibacterial polypeptides from guinea pig neutrophils. Arch Biochem Biophys 1996; 328: 219-26.
14. [14] Nagaoka I, Tsutsumi-Ishii Y, Yomogida S, Yamashita T. Isolation of cDNA encoding guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and evaluation of CAP11 mRNA expression during neutrophil maturation. J Biol Chem 1997; 272: 22742-50.
15. [15] Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, Salcedo R. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 1996; 238: 325-32.
16. [16] Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997; 89: 3503-21.
17. [17] Gullberg U, Andersson E, Garwicz D, Lindmark A, Olsson I. Biosynthesis, processing and sorting of neutrophil proteins: insight into neutrophil granule development. Eur J Haematol 1997; 58: 137-53.
18. [18] Cowland JB, Johnsen AH, Borregaard N. hCAP-18, a cathelin/ pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett 1995; 368: 173-6.
19. [19] Sørensen O, Arnljots K, Cowland JB, Bainton DF, Borregaard N. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 1997; 90: 2796-803.
20. [20] Nagaoka I, Hirata M, Sugimoto K, Tsutsumi-Ishii Y, Someya A, Saionji K, Igari J. Evaluation of the expression of human CAP18 gene during neutrophil maturation in the bone marrow. J Leukoc Biol 1998; 64: 845-52.
21. [21] Ganz T. Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes. Infect Immun 1987; 55: 568-71.
22. [22] Yomogida S, Nagaoka I, Yamashita T. Comparative studies on the extracellular release and biological activity of guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and defensins. Comp Biochem Physiol 1997; 116B: 99-107.
23. [23] Yamashita T, Saito K. Purification, primary structure, and biological activity of guinea pig neutrophil cationic peptides. Infect Immun 1989; 57: 2405-9.
24. [24] Lehrer RI, Barton A, Ganz T. Concurrent assessment of inner and outer membrane permeabilization and bacteriolysis in E. coli by multiple-wavelength spectrophotometry. J Immunol Methods 1988; 108: 153-8.
25. [25] Gennaro R, Scocchi M, Merluzzi L, Zanetti M. Biological characterization of a novel mammalian antimicrobial peptide. Biochem Biophys Acta 1998; 1425: 361-8.
26. [26] Ellison RT, Giehl TJ. Killing of Gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 1991; 88: 1080-91.
27. [27] Bals R, Wang X, Zasloff M, Wilson JM. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 1998; 95: 9541-6.
28. [28] Ganz T, Selsted ME, Szklarek D, Harwig SSL, Daher K, Bainton DF, et al. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 1985; 76: 1427-35.
29. [29] Tossi A, Scocchi M, Skerlavaj B, Gennaro R. Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes. FEBS Lett 1994; 339: 108-12.
30. [30] Matsuzaki K, Sugishita K, Harada M, Fujii N, Miyajima K. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochem Biophys Acta 1997; 1327: 119-30.
31. [31] Lehrer RI, Barton A, Daher KA, Harwig SSL, Ganz T, Selsted ME. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest 1989; 84: 553-61.
32. [32] Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM. Human β-defensin-1 is a slat-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997; 88: 553-60.